KORU Medical Systems Q1 2024 Adj EPS $(0.02) Beats $(0.04) Estimate, Sales $8.198M Beat $7.467M Estimate
Portfolio Pulse from Benzinga Newsdesk
KORU Medical Systems (NASDAQ:KRMD) reported Q1 2024 earnings with an adjusted EPS of $(0.02), surpassing the $(0.04) estimate, and sales of $8.198M, exceeding the $7.467M forecast. This represents a 50% improvement in EPS and a 10.89% increase in sales compared to the same period last year.
May 01, 2024 | 9:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
KORU Medical Systems reported a better-than-expected Q1 2024 performance with an adjusted EPS of $(0.02) and sales of $8.198M, beating both EPS and sales estimates.
KORU Medical Systems' Q1 2024 earnings report exceeded analyst expectations in both EPS and sales, indicating a strong financial performance and potential growth. The significant improvement in EPS and sales compared to the same period last year suggests operational efficiency and market demand for their products. This positive earnings report is likely to instill investor confidence and could lead to a short-term uptick in KRMD's stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100